Profil
René Goedkoop, former Medical Director & Head-Clinical Development at IsoTis SA, VP-Clinical Development & Medical Director at Apoxis SA, Director at Neovacs SA, Medical Director at Serono International SA, Medical Affairs Associate at Centocor, Inc., Clinical Research Physician at Eli Lilly & Co., VP-Clinical Development Europe Division at Ocera Therapeutics, Inc., Chief Medical Officer at Sensimed SA, EryDel SpA, and Pharnext SA, served as the Chief Medical Officer at MediGene AG from 2021 to 2023.
Dr. Goedkoop obtained a doctorate degree from the University of Amsterdam.
Anciens postes connus de René Goedkoop
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIGENE AG | Chief Tech/Sci/R&D Officer | 01/04/2023 |
EryDel SpA
 EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Chief Tech/Sci/R&D Officer | - |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | - |
| PHARNEXT SCA | Chief Tech/Sci/R&D Officer | - |
| Serono International SA | Chief Tech/Sci/R&D Officer | - |
Formation de René Goedkoop
| University of Amsterdam | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MEDIGENE AG | Health Technology |
| NEOVACS | Health Technology |
| PHARNEXT SCA | Health Technology |
| Entreprise privées | 7 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
IsoTis SA
 IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Health Technology |
Apoxis SA
 Apoxis SA Pharmaceuticals: MajorHealth Technology Apoxis SA develops therapeutics for the treatment of cancer and immunological diseases based on the mechanisms underlying apoptosis or cell death. The company particularly focuses on diseases with unmet medical needs and high commercial potential. It's lead product, APO866, is a novel small molecule therapeutic for the treatment of a range of cancers. The product is also being evaluated in a range of cancers in combination with commonly used chemo and radiotherapies in preclinical studies. It's oncology portfolio also includes APO010, a protein therapeutic that was developed using the company’s proprietary multimerization technology. The company is headquartered in Lausanne, Switzerland. | Health Technology |
Ocera Therapeutics, Inc. /Old/
 Ocera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. is a San Diego based, privately held biopharmaceutical company founded in January 2005 by Dr. Eckard Weber and Dr. Laurent Fischer. Ocera focuses on the development of novel therapeutics in the areas of liver and gastrointestinal diseases. | Health Technology |
Sensimed SA
 Sensimed SA Medical SpecialtiesHealth Technology Sensimed SA develops non-invasive soft contact lens-based solutions. It offers solutions to monitor fluctuations in intraocular pressure continuously. The company was founded by Matteo Leonardi and Sacha Cerboni in 2003 and is headquartered in Lausanne, Switzerland. | Health Technology |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
| Serono International SA |
